SEC INSIDER TRANSACTIONS

AMAZON COM INC (AMZN) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

AMZN · AMAZON COM INC

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 31 filings · fetched 2026-11-13T16:38:32Z

Recent reported activity

0purchase rows on this page

13sale rows on this page

130matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-05-21Filed 2026-05-26	Herrington Douglas JOfficer · CEO Worldwide Amazon Stores Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.47 and the lowest price at which shares were sold was $261.52. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.43 and the lowest price at which shares were sold was $262.59. F4 Represents the weighted average sale price. The highest price at which shares were sold was $263.90 and the lowest price at which shares were sold was $263.63. F5 Converts into Common Stock on a one-for-one basis. F6 This award vests based upon the following vesting schedule: 7,500 shares on each of May 21, 2023, August 21, 2023, November 21, 2023, February 21, 2024, May 21, 2026, August 21, 2026, November 21, 2026, and February 21, 2027. F7 This award vests based upon the following vesting schedule: 2,600 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,520 shares on May 21, 2025; 3,500 shares on each of August 21, 2025, November 21, 2025, and February 21, 2026; 2,860 shares on May 21, 2026; 2,840 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,980 shares on May 21, 2027; and 7,960 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028. F8 This award vests based upon the following vesting schedule: 3,827 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; 5,565 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 5,564 shares on February 21, 2027; 6,785 shares on May 21, 2027; 6,784 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028; 17,162 shares on each of May 21, 2028 and August 21, 2028; 17,161 shares on each of November 21, 2028 and February 21, 2029; 13,236 shares on each of May 21, 2029, August 21, 2029, and November 21, 2029; and 13,235 shares on February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References:	M Exercise / conversionCommon Stock, par value $.01 per share · Non-derivative	7,500A	0	Direct	Form 4 ↗0001018724-26-000020
2026-05-21Filed 2026-05-26	Reynolds ShelleyOfficer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/11/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.39 and the lowest price at which shares were sold was $261.50. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.46 and the lowest price at which shares were sold was $262.87. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.17 and the lowest price at which shares were sold was $263.90. F5 Converts into Common Stock on a one-for-one basis. F6 This award vests based upon the following vesting schedule: 80 shares on each of May 21, 2023, August 21, 2023, and November 21, 2023; 60 shares on February 21, 2024; 360 shares on each of May 21, 2024 and August 21, 2024; 340 shares on each of November 21, 2024 and February 21, 2025; 560 shares on each of May 21, 2025 and August 21, 2025; 540 shares on each of November 21, 2025 and February 21, 2026; 1,820 shares on May 21, 2026; 1,800 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; and 1,360 shares on each of May 21, 2027, August 21, 2027, November 21, 2027, and February 21, 2028. F7 This award vests based upon the following vesting schedule: 2,772 shares on each of August 21, 2024 and November 21, 2024; 2,771 shares on February 21, 2025; 355 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; 543 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 542 shares on February 21, 2027; 682 shares on each of May 21, 2027 and August 21, 2027; 681 shares on each of November 21, 2027 and February 21, 2028; 1,569 shares on each of May 21, 2028, August 21, 2028, November 21, 2028, and February 21, 2029; 1,185 shares on each of May 21, 2029, August 21, 2029, and November 21, 2029; and 1,184 shares on February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F5, F7	M Exercise / conversionRestricted Stock Unit Award · Derivative	543D	0	Direct	Form 4 ↗0001018724-26-000018
2026-05-21Filed 2026-05-26	Reynolds ShelleyOfficer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/11/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.39 and the lowest price at which shares were sold was $261.50. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.46 and the lowest price at which shares were sold was $262.87. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.17 and the lowest price at which shares were sold was $263.90. F5 Converts into Common Stock on a one-for-one basis. F6 This award vests based upon the following vesting schedule: 80 shares on each of May 21, 2023, August 21, 2023, and November 21, 2023; 60 shares on February 21, 2024; 360 shares on each of May 21, 2024 and August 21, 2024; 340 shares on each of November 21, 2024 and February 21, 2025; 560 shares on each of May 21, 2025 and August 21, 2025; 540 shares on each of November 21, 2025 and February 21, 2026; 1,820 shares on May 21, 2026; 1,800 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; and 1,360 shares on each of May 21, 2027, August 21, 2027, November 21, 2027, and February 21, 2028. F7 This award vests based upon the following vesting schedule: 2,772 shares on each of August 21, 2024 and November 21, 2024; 2,771 shares on February 21, 2025; 355 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; 543 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 542 shares on February 21, 2027; 682 shares on each of May 21, 2027 and August 21, 2027; 681 shares on each of November 21, 2027 and February 21, 2028; 1,569 shares on each of May 21, 2028, August 21, 2028, November 21, 2028, and February 21, 2029; 1,185 shares on each of May 21, 2029, August 21, 2029, and November 21, 2029; and 1,184 shares on February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F5, F6	M Exercise / conversionRestricted Stock Unit Award · Derivative	1,820D	0	Direct	Form 4 ↗0001018724-26-000018
2026-05-21Filed 2026-05-26	Reynolds ShelleyOfficer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/11/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.39 and the lowest price at which shares were sold was $261.50. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.46 and the lowest price at which shares were sold was $262.87. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.17 and the lowest price at which shares were sold was $263.90. F5 Converts into Common Stock on a one-for-one basis. F6 This award vests based upon the following vesting schedule: 80 shares on each of May 21, 2023, August 21, 2023, and November 21, 2023; 60 shares on February 21, 2024; 360 shares on each of May 21, 2024 and August 21, 2024; 340 shares on each of November 21, 2024 and February 21, 2025; 560 shares on each of May 21, 2025 and August 21, 2025; 540 shares on each of November 21, 2025 and February 21, 2026; 1,820 shares on May 21, 2026; 1,800 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; and 1,360 shares on each of May 21, 2027, August 21, 2027, November 21, 2027, and February 21, 2028. F7 This award vests based upon the following vesting schedule: 2,772 shares on each of August 21, 2024 and November 21, 2024; 2,771 shares on February 21, 2025; 355 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; 543 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 542 shares on February 21, 2027; 682 shares on each of May 21, 2027 and August 21, 2027; 681 shares on each of November 21, 2027 and February 21, 2028; 1,569 shares on each of May 21, 2028, August 21, 2028, November 21, 2028, and February 21, 2029; 1,185 shares on each of May 21, 2029, August 21, 2029, and November 21, 2029; and 1,184 shares on February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F1, F4	S Sale (market/private)Common Stock, par value $.01 per share · Non-derivative	300D	263.99	Direct	Form 4 ↗0001018724-26-000018
2026-05-21Filed 2026-05-26	Reynolds ShelleyOfficer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/11/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.39 and the lowest price at which shares were sold was $261.50. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.46 and the lowest price at which shares were sold was $262.87. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.17 and the lowest price at which shares were sold was $263.90. F5 Converts into Common Stock on a one-for-one basis. F6 This award vests based upon the following vesting schedule: 80 shares on each of May 21, 2023, August 21, 2023, and November 21, 2023; 60 shares on February 21, 2024; 360 shares on each of May 21, 2024 and August 21, 2024; 340 shares on each of November 21, 2024 and February 21, 2025; 560 shares on each of May 21, 2025 and August 21, 2025; 540 shares on each of November 21, 2025 and February 21, 2026; 1,820 shares on May 21, 2026; 1,800 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; and 1,360 shares on each of May 21, 2027, August 21, 2027, November 21, 2027, and February 21, 2028. F7 This award vests based upon the following vesting schedule: 2,772 shares on each of August 21, 2024 and November 21, 2024; 2,771 shares on February 21, 2025; 355 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; 543 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 542 shares on February 21, 2027; 682 shares on each of May 21, 2027 and August 21, 2027; 681 shares on each of November 21, 2027 and February 21, 2028; 1,569 shares on each of May 21, 2028, August 21, 2028, November 21, 2028, and February 21, 2029; 1,185 shares on each of May 21, 2029, August 21, 2029, and November 21, 2029; and 1,184 shares on February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F1, F3	S Sale (market/private)Common Stock, par value $.01 per share · Non-derivative	463D	263.2466	Direct	Form 4 ↗0001018724-26-000018
2026-05-21Filed 2026-05-26	Reynolds ShelleyOfficer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/11/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.39 and the lowest price at which shares were sold was $261.50. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.46 and the lowest price at which shares were sold was $262.87. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.17 and the lowest price at which shares were sold was $263.90. F5 Converts into Common Stock on a one-for-one basis. F6 This award vests based upon the following vesting schedule: 80 shares on each of May 21, 2023, August 21, 2023, and November 21, 2023; 60 shares on February 21, 2024; 360 shares on each of May 21, 2024 and August 21, 2024; 340 shares on each of November 21, 2024 and February 21, 2025; 560 shares on each of May 21, 2025 and August 21, 2025; 540 shares on each of November 21, 2025 and February 21, 2026; 1,820 shares on May 21, 2026; 1,800 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; and 1,360 shares on each of May 21, 2027, August 21, 2027, November 21, 2027, and February 21, 2028. F7 This award vests based upon the following vesting schedule: 2,772 shares on each of August 21, 2024 and November 21, 2024; 2,771 shares on February 21, 2025; 355 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; 543 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 542 shares on February 21, 2027; 682 shares on each of May 21, 2027 and August 21, 2027; 681 shares on each of November 21, 2027 and February 21, 2028; 1,569 shares on each of May 21, 2028, August 21, 2028, November 21, 2028, and February 21, 2029; 1,185 shares on each of May 21, 2029, August 21, 2029, and November 21, 2029; and 1,184 shares on February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F1, F2	S Sale (market/private)Common Stock, par value $.01 per share · Non-derivative	1,600D	261.8269	Direct	Form 4 ↗0001018724-26-000018
2026-05-21Filed 2026-05-26	Reynolds ShelleyOfficer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/11/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.39 and the lowest price at which shares were sold was $261.50. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.46 and the lowest price at which shares were sold was $262.87. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.17 and the lowest price at which shares were sold was $263.90. F5 Converts into Common Stock on a one-for-one basis. F6 This award vests based upon the following vesting schedule: 80 shares on each of May 21, 2023, August 21, 2023, and November 21, 2023; 60 shares on February 21, 2024; 360 shares on each of May 21, 2024 and August 21, 2024; 340 shares on each of November 21, 2024 and February 21, 2025; 560 shares on each of May 21, 2025 and August 21, 2025; 540 shares on each of November 21, 2025 and February 21, 2026; 1,820 shares on May 21, 2026; 1,800 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; and 1,360 shares on each of May 21, 2027, August 21, 2027, November 21, 2027, and February 21, 2028. F7 This award vests based upon the following vesting schedule: 2,772 shares on each of August 21, 2024 and November 21, 2024; 2,771 shares on February 21, 2025; 355 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; 543 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 542 shares on February 21, 2027; 682 shares on each of May 21, 2027 and August 21, 2027; 681 shares on each of November 21, 2027 and February 21, 2028; 1,569 shares on each of May 21, 2028, August 21, 2028, November 21, 2028, and February 21, 2029; 1,185 shares on each of May 21, 2029, August 21, 2029, and November 21, 2029; and 1,184 shares on February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References:	M Exercise / conversionCommon Stock, par value $.01 per share · Non-derivative	543A	0	Direct	Form 4 ↗0001018724-26-000018
2026-05-21Filed 2026-05-26	Reynolds ShelleyOfficer · Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/11/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.39 and the lowest price at which shares were sold was $261.50. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.46 and the lowest price at which shares were sold was $262.87. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.17 and the lowest price at which shares were sold was $263.90. F5 Converts into Common Stock on a one-for-one basis. F6 This award vests based upon the following vesting schedule: 80 shares on each of May 21, 2023, August 21, 2023, and November 21, 2023; 60 shares on February 21, 2024; 360 shares on each of May 21, 2024 and August 21, 2024; 340 shares on each of November 21, 2024 and February 21, 2025; 560 shares on each of May 21, 2025 and August 21, 2025; 540 shares on each of November 21, 2025 and February 21, 2026; 1,820 shares on May 21, 2026; 1,800 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; and 1,360 shares on each of May 21, 2027, August 21, 2027, November 21, 2027, and February 21, 2028. F7 This award vests based upon the following vesting schedule: 2,772 shares on each of August 21, 2024 and November 21, 2024; 2,771 shares on February 21, 2025; 355 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; 543 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 542 shares on February 21, 2027; 682 shares on each of May 21, 2027 and August 21, 2027; 681 shares on each of November 21, 2027 and February 21, 2028; 1,569 shares on each of May 21, 2028, August 21, 2028, November 21, 2028, and February 21, 2029; 1,185 shares on each of May 21, 2029, August 21, 2029, and November 21, 2029; and 1,184 shares on February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References:	M Exercise / conversionCommon Stock, par value $.01 per share · Non-derivative	1,820A	0	Direct	Form 4 ↗0001018724-26-000018
2026-05-21Filed 2026-05-26	Jassy Andrew RDirector · Officer · President and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.46 and the lowest price at which shares were sold was $261.47. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.47 and the lowest price at which shares were sold was $262.48. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.48 and the lowest price at which shares were sold was $263.50. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.57 and the lowest price at which shares were sold was $264.58. F6 Represents the weighted average sale price. The highest price at which shares were sold was $265.64 and the lowest price at which shares were sold was $265.60. F7 Converts into Common Stock on a one-for-one basis. F8 This award vests based upon the following vesting schedule: 10,000 shares on each of May 21, 2023, August 21, 2023, November 21, 2023, and February 21, 2024; 20,000 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 25,000 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; and 50,000 shares on each of May 21, 2026, August 21, 2026, November 21, 2026, February 21, 2027, May 21, 2027, August 21, 2027, November 21, 2027, February 21, 2028, May 21, 2028, August 21, 2028, November 21, 2028, February 21, 2029, May 21, 2029, August 21, 2029, November 21, 2029, February 21, 2030, May 21, 2030, August 21, 2030, November 21, 2030, and February 21, 2031. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F7, F8	M Exercise / conversionRestricted Stock Unit Award · Derivative	50,000D	0	Direct	Form 4 ↗0001374545-26-000008
2026-05-21Filed 2026-05-26	Jassy Andrew RDirector · Officer · President and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.46 and the lowest price at which shares were sold was $261.47. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.47 and the lowest price at which shares were sold was $262.48. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.48 and the lowest price at which shares were sold was $263.50. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.57 and the lowest price at which shares were sold was $264.58. F6 Represents the weighted average sale price. The highest price at which shares were sold was $265.64 and the lowest price at which shares were sold was $265.60. F7 Converts into Common Stock on a one-for-one basis. F8 This award vests based upon the following vesting schedule: 10,000 shares on each of May 21, 2023, August 21, 2023, November 21, 2023, and February 21, 2024; 20,000 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 25,000 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; and 50,000 shares on each of May 21, 2026, August 21, 2026, November 21, 2026, February 21, 2027, May 21, 2027, August 21, 2027, November 21, 2027, February 21, 2028, May 21, 2028, August 21, 2028, November 21, 2028, February 21, 2029, May 21, 2029, August 21, 2029, November 21, 2029, February 21, 2030, May 21, 2030, August 21, 2030, November 21, 2030, and February 21, 2031. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F1, F6	S Sale (market/private)Common Stock, par value $.01 per share · Non-derivative	300D	265.6148	Direct	Form 4 ↗0001374545-26-000008
2026-05-21Filed 2026-05-26	Jassy Andrew RDirector · Officer · President and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.46 and the lowest price at which shares were sold was $261.47. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.47 and the lowest price at which shares were sold was $262.48. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.48 and the lowest price at which shares were sold was $263.50. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.57 and the lowest price at which shares were sold was $264.58. F6 Represents the weighted average sale price. The highest price at which shares were sold was $265.64 and the lowest price at which shares were sold was $265.60. F7 Converts into Common Stock on a one-for-one basis. F8 This award vests based upon the following vesting schedule: 10,000 shares on each of May 21, 2023, August 21, 2023, November 21, 2023, and February 21, 2024; 20,000 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 25,000 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; and 50,000 shares on each of May 21, 2026, August 21, 2026, November 21, 2026, February 21, 2027, May 21, 2027, August 21, 2027, November 21, 2027, February 21, 2028, May 21, 2028, August 21, 2028, November 21, 2028, February 21, 2029, May 21, 2029, August 21, 2029, November 21, 2029, February 21, 2030, May 21, 2030, August 21, 2030, November 21, 2030, and February 21, 2031. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F1, F5	S Sale (market/private)Common Stock, par value $.01 per share · Non-derivative	3,600D	264.9745	Direct	Form 4 ↗0001374545-26-000008
2026-05-21Filed 2026-05-26	Jassy Andrew RDirector · Officer · President and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.46 and the lowest price at which shares were sold was $261.47. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.47 and the lowest price at which shares were sold was $262.48. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.48 and the lowest price at which shares were sold was $263.50. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.57 and the lowest price at which shares were sold was $264.58. F6 Represents the weighted average sale price. The highest price at which shares were sold was $265.64 and the lowest price at which shares were sold was $265.60. F7 Converts into Common Stock on a one-for-one basis. F8 This award vests based upon the following vesting schedule: 10,000 shares on each of May 21, 2023, August 21, 2023, November 21, 2023, and February 21, 2024; 20,000 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 25,000 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; and 50,000 shares on each of May 21, 2026, August 21, 2026, November 21, 2026, February 21, 2027, May 21, 2027, August 21, 2027, November 21, 2027, February 21, 2028, May 21, 2028, August 21, 2028, November 21, 2028, February 21, 2029, May 21, 2029, August 21, 2029, November 21, 2029, February 21, 2030, May 21, 2030, August 21, 2030, November 21, 2030, and February 21, 2031. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F1, F4	S Sale (market/private)Common Stock, par value $.01 per share · Non-derivative	5,667D	263.9465	Direct	Form 4 ↗0001374545-26-000008
2026-05-21Filed 2026-05-26	Jassy Andrew RDirector · Officer · President and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.46 and the lowest price at which shares were sold was $261.47. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.47 and the lowest price at which shares were sold was $262.48. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.48 and the lowest price at which shares were sold was $263.50. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.57 and the lowest price at which shares were sold was $264.58. F6 Represents the weighted average sale price. The highest price at which shares were sold was $265.64 and the lowest price at which shares were sold was $265.60. F7 Converts into Common Stock on a one-for-one basis. F8 This award vests based upon the following vesting schedule: 10,000 shares on each of May 21, 2023, August 21, 2023, November 21, 2023, and February 21, 2024; 20,000 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 25,000 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; and 50,000 shares on each of May 21, 2026, August 21, 2026, November 21, 2026, February 21, 2027, May 21, 2027, August 21, 2027, November 21, 2027, February 21, 2028, May 21, 2028, August 21, 2028, November 21, 2028, February 21, 2029, May 21, 2029, August 21, 2029, November 21, 2029, February 21, 2030, May 21, 2030, August 21, 2030, November 21, 2030, and February 21, 2031. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F1, F3	S Sale (market/private)Common Stock, par value $.01 per share · Non-derivative	5,227D	263.1028	Direct	Form 4 ↗0001374545-26-000008
2026-05-21Filed 2026-05-26	Jassy Andrew RDirector · Officer · President and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.46 and the lowest price at which shares were sold was $261.47. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.47 and the lowest price at which shares were sold was $262.48. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.48 and the lowest price at which shares were sold was $263.50. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.57 and the lowest price at which shares were sold was $264.58. F6 Represents the weighted average sale price. The highest price at which shares were sold was $265.64 and the lowest price at which shares were sold was $265.60. F7 Converts into Common Stock on a one-for-one basis. F8 This award vests based upon the following vesting schedule: 10,000 shares on each of May 21, 2023, August 21, 2023, November 21, 2023, and February 21, 2024; 20,000 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 25,000 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; and 50,000 shares on each of May 21, 2026, August 21, 2026, November 21, 2026, February 21, 2027, May 21, 2027, August 21, 2027, November 21, 2027, February 21, 2028, May 21, 2028, August 21, 2028, November 21, 2028, February 21, 2029, May 21, 2029, August 21, 2029, November 21, 2029, February 21, 2030, May 21, 2030, August 21, 2030, November 21, 2030, and February 21, 2031. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F1, F2	S Sale (market/private)Common Stock, par value $.01 per share · Non-derivative	5,206D	261.9528	Direct	Form 4 ↗0001374545-26-000008
2026-05-21Filed 2026-05-26	Jassy Andrew RDirector · Officer · President and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.46 and the lowest price at which shares were sold was $261.47. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.47 and the lowest price at which shares were sold was $262.48. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.48 and the lowest price at which shares were sold was $263.50. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.57 and the lowest price at which shares were sold was $264.58. F6 Represents the weighted average sale price. The highest price at which shares were sold was $265.64 and the lowest price at which shares were sold was $265.60. F7 Converts into Common Stock on a one-for-one basis. F8 This award vests based upon the following vesting schedule: 10,000 shares on each of May 21, 2023, August 21, 2023, November 21, 2023, and February 21, 2024; 20,000 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 25,000 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; and 50,000 shares on each of May 21, 2026, August 21, 2026, November 21, 2026, February 21, 2027, May 21, 2027, August 21, 2027, November 21, 2027, February 21, 2028, May 21, 2028, August 21, 2028, November 21, 2028, February 21, 2029, May 21, 2029, August 21, 2029, November 21, 2029, February 21, 2030, May 21, 2030, August 21, 2030, November 21, 2030, and February 21, 2031. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References:	M Exercise / conversionCommon Stock, par value $.01 per share · Non-derivative	50,000A	0	Direct	Form 4 ↗0001374545-26-000008
2026-05-21Filed 2026-05-26	Zapolsky DavidOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/03/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.57 and the lowest price at which shares were sold was $261.57. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.56 and the lowest price at which shares were sold was $262.57. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.58 and the lowest price at which shares were sold was $263.60. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.65 and the lowest price at which shares were sold was $264.66. F6 Converts into Common Stock on a one-for-one basis. F7 This award vests based upon the following vesting schedule: 2,260 shares on May 21, 2023; 2,240 shares on each of August 21, 2023, November 21, 2023, and February 21, 2024; 3,240 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,940 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 3,920 shares on February 21, 2026; 9,920 shares on May 21, 2026; 9,900 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,640 shares on May 21, 2027; and 7,620 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028. F8 This award vests based upon the following vesting schedule: 5,050 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 5,049 shares on February 21, 2026; 5,530 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 5,529 shares on February 21, 2027; 5,797 shares on each of May 21, 2027 and August 21, 2027; 5,796 shares on each of November 21, 2027 and February 21, 2028; 10,474 shares on each of May 21, 2028, August 21, 2028, and November 21, 2028; 10,473 shares on February 21, 2029; 8,067 shares on each of May 21, 2029 and August 21, 2029; and 8,066 shares on each of November 21, 2029 and February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F6, F8	M Exercise / conversionRestricted Stock Unit Award · Derivative	5,530D	0	Direct	Form 4 ↗0001557979-26-000006
2026-05-21Filed 2026-05-26	Zapolsky DavidOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/03/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.57 and the lowest price at which shares were sold was $261.57. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.56 and the lowest price at which shares were sold was $262.57. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.58 and the lowest price at which shares were sold was $263.60. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.65 and the lowest price at which shares were sold was $264.66. F6 Converts into Common Stock on a one-for-one basis. F7 This award vests based upon the following vesting schedule: 2,260 shares on May 21, 2023; 2,240 shares on each of August 21, 2023, November 21, 2023, and February 21, 2024; 3,240 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,940 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 3,920 shares on February 21, 2026; 9,920 shares on May 21, 2026; 9,900 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,640 shares on May 21, 2027; and 7,620 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028. F8 This award vests based upon the following vesting schedule: 5,050 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 5,049 shares on February 21, 2026; 5,530 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 5,529 shares on February 21, 2027; 5,797 shares on each of May 21, 2027 and August 21, 2027; 5,796 shares on each of November 21, 2027 and February 21, 2028; 10,474 shares on each of May 21, 2028, August 21, 2028, and November 21, 2028; 10,473 shares on February 21, 2029; 8,067 shares on each of May 21, 2029 and August 21, 2029; and 8,066 shares on each of November 21, 2029 and February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F6, F7	M Exercise / conversionRestricted Stock Unit Award · Derivative	9,920D	0	Direct	Form 4 ↗0001557979-26-000006
2026-05-21Filed 2026-05-26	Zapolsky DavidOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/03/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.57 and the lowest price at which shares were sold was $261.57. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.56 and the lowest price at which shares were sold was $262.57. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.58 and the lowest price at which shares were sold was $263.60. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.65 and the lowest price at which shares were sold was $264.66. F6 Converts into Common Stock on a one-for-one basis. F7 This award vests based upon the following vesting schedule: 2,260 shares on May 21, 2023; 2,240 shares on each of August 21, 2023, November 21, 2023, and February 21, 2024; 3,240 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,940 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 3,920 shares on February 21, 2026; 9,920 shares on May 21, 2026; 9,900 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,640 shares on May 21, 2027; and 7,620 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028. F8 This award vests based upon the following vesting schedule: 5,050 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 5,049 shares on February 21, 2026; 5,530 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 5,529 shares on February 21, 2027; 5,797 shares on each of May 21, 2027 and August 21, 2027; 5,796 shares on each of November 21, 2027 and February 21, 2028; 10,474 shares on each of May 21, 2028, August 21, 2028, and November 21, 2028; 10,473 shares on February 21, 2029; 8,067 shares on each of May 21, 2029 and August 21, 2029; and 8,066 shares on each of November 21, 2029 and February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F1	S Sale (market/private)Common Stock, par value $.01 per share · Non-derivative	1D	265.72	Direct	Form 4 ↗0001557979-26-000006
2026-05-21Filed 2026-05-26	Zapolsky DavidOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/03/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.57 and the lowest price at which shares were sold was $261.57. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.56 and the lowest price at which shares were sold was $262.57. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.58 and the lowest price at which shares were sold was $263.60. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.65 and the lowest price at which shares were sold was $264.66. F6 Converts into Common Stock on a one-for-one basis. F7 This award vests based upon the following vesting schedule: 2,260 shares on May 21, 2023; 2,240 shares on each of August 21, 2023, November 21, 2023, and February 21, 2024; 3,240 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,940 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 3,920 shares on February 21, 2026; 9,920 shares on May 21, 2026; 9,900 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,640 shares on May 21, 2027; and 7,620 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028. F8 This award vests based upon the following vesting schedule: 5,050 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 5,049 shares on February 21, 2026; 5,530 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 5,529 shares on February 21, 2027; 5,797 shares on each of May 21, 2027 and August 21, 2027; 5,796 shares on each of November 21, 2027 and February 21, 2028; 10,474 shares on each of May 21, 2028, August 21, 2028, and November 21, 2028; 10,473 shares on February 21, 2029; 8,067 shares on each of May 21, 2029 and August 21, 2029; and 8,066 shares on each of November 21, 2029 and February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F1, F5	S Sale (market/private)Common Stock, par value $.01 per share · Non-derivative	1,014D	265.12	Direct	Form 4 ↗0001557979-26-000006
2026-05-21Filed 2026-05-26	Zapolsky DavidOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/03/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.57 and the lowest price at which shares were sold was $261.57. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.56 and the lowest price at which shares were sold was $262.57. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.58 and the lowest price at which shares were sold was $263.60. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.65 and the lowest price at which shares were sold was $264.66. F6 Converts into Common Stock on a one-for-one basis. F7 This award vests based upon the following vesting schedule: 2,260 shares on May 21, 2023; 2,240 shares on each of August 21, 2023, November 21, 2023, and February 21, 2024; 3,240 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,940 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 3,920 shares on February 21, 2026; 9,920 shares on May 21, 2026; 9,900 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,640 shares on May 21, 2027; and 7,620 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028. F8 This award vests based upon the following vesting schedule: 5,050 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 5,049 shares on February 21, 2026; 5,530 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 5,529 shares on February 21, 2027; 5,797 shares on each of May 21, 2027 and August 21, 2027; 5,796 shares on each of November 21, 2027 and February 21, 2028; 10,474 shares on each of May 21, 2028, August 21, 2028, and November 21, 2028; 10,473 shares on February 21, 2029; 8,067 shares on each of May 21, 2029 and August 21, 2029; and 8,066 shares on each of November 21, 2029 and February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F1, F4	S Sale (market/private)Common Stock, par value $.01 per share · Non-derivative	1,644D	264.1187	Direct	Form 4 ↗0001557979-26-000006
2026-05-21Filed 2026-05-26	Zapolsky DavidOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/03/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.57 and the lowest price at which shares were sold was $261.57. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.56 and the lowest price at which shares were sold was $262.57. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.58 and the lowest price at which shares were sold was $263.60. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.65 and the lowest price at which shares were sold was $264.66. F6 Converts into Common Stock on a one-for-one basis. F7 This award vests based upon the following vesting schedule: 2,260 shares on May 21, 2023; 2,240 shares on each of August 21, 2023, November 21, 2023, and February 21, 2024; 3,240 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,940 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 3,920 shares on February 21, 2026; 9,920 shares on May 21, 2026; 9,900 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,640 shares on May 21, 2027; and 7,620 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028. F8 This award vests based upon the following vesting schedule: 5,050 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 5,049 shares on February 21, 2026; 5,530 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 5,529 shares on February 21, 2027; 5,797 shares on each of May 21, 2027 and August 21, 2027; 5,796 shares on each of November 21, 2027 and February 21, 2028; 10,474 shares on each of May 21, 2028, August 21, 2028, and November 21, 2028; 10,473 shares on February 21, 2029; 8,067 shares on each of May 21, 2029 and August 21, 2029; and 8,066 shares on each of November 21, 2029 and February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F1, F3	S Sale (market/private)Common Stock, par value $.01 per share · Non-derivative	1,921D	263.1658	Direct	Form 4 ↗0001557979-26-000006
2026-05-21Filed 2026-05-26	Zapolsky DavidOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/03/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.57 and the lowest price at which shares were sold was $261.57. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.56 and the lowest price at which shares were sold was $262.57. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.58 and the lowest price at which shares were sold was $263.60. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.65 and the lowest price at which shares were sold was $264.66. F6 Converts into Common Stock on a one-for-one basis. F7 This award vests based upon the following vesting schedule: 2,260 shares on May 21, 2023; 2,240 shares on each of August 21, 2023, November 21, 2023, and February 21, 2024; 3,240 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,940 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 3,920 shares on February 21, 2026; 9,920 shares on May 21, 2026; 9,900 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,640 shares on May 21, 2027; and 7,620 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028. F8 This award vests based upon the following vesting schedule: 5,050 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 5,049 shares on February 21, 2026; 5,530 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 5,529 shares on February 21, 2027; 5,797 shares on each of May 21, 2027 and August 21, 2027; 5,796 shares on each of November 21, 2027 and February 21, 2028; 10,474 shares on each of May 21, 2028, August 21, 2028, and November 21, 2028; 10,473 shares on February 21, 2029; 8,067 shares on each of May 21, 2029 and August 21, 2029; and 8,066 shares on each of November 21, 2029 and February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References: F1, F2	S Sale (market/private)Common Stock, par value $.01 per share · Non-derivative	1,600D	261.9554	Direct	Form 4 ↗0001557979-26-000006
2026-05-21Filed 2026-05-26	Zapolsky DavidOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/03/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.57 and the lowest price at which shares were sold was $261.57. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.56 and the lowest price at which shares were sold was $262.57. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.58 and the lowest price at which shares were sold was $263.60. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.65 and the lowest price at which shares were sold was $264.66. F6 Converts into Common Stock on a one-for-one basis. F7 This award vests based upon the following vesting schedule: 2,260 shares on May 21, 2023; 2,240 shares on each of August 21, 2023, November 21, 2023, and February 21, 2024; 3,240 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,940 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 3,920 shares on February 21, 2026; 9,920 shares on May 21, 2026; 9,900 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,640 shares on May 21, 2027; and 7,620 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028. F8 This award vests based upon the following vesting schedule: 5,050 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 5,049 shares on February 21, 2026; 5,530 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 5,529 shares on February 21, 2027; 5,797 shares on each of May 21, 2027 and August 21, 2027; 5,796 shares on each of November 21, 2027 and February 21, 2028; 10,474 shares on each of May 21, 2028, August 21, 2028, and November 21, 2028; 10,473 shares on February 21, 2029; 8,067 shares on each of May 21, 2029 and August 21, 2029; and 8,066 shares on each of November 21, 2029 and February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References:	M Exercise / conversionCommon Stock, par value $.01 per share · Non-derivative	5,530A	0	Direct	Form 4 ↗0001557979-26-000006
2026-05-21Filed 2026-05-26	Zapolsky DavidOfficer · Senior Vice President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/03/2025. F2 Represents the weighted average sale price. The highest price at which shares were sold was $262.57 and the lowest price at which shares were sold was $261.57. F3 Represents the weighted average sale price. The highest price at which shares were sold was $263.56 and the lowest price at which shares were sold was $262.57. F4 Represents the weighted average sale price. The highest price at which shares were sold was $264.58 and the lowest price at which shares were sold was $263.60. F5 Represents the weighted average sale price. The highest price at which shares were sold was $265.65 and the lowest price at which shares were sold was $264.66. F6 Converts into Common Stock on a one-for-one basis. F7 This award vests based upon the following vesting schedule: 2,260 shares on May 21, 2023; 2,240 shares on each of August 21, 2023, November 21, 2023, and February 21, 2024; 3,240 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,940 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 3,920 shares on February 21, 2026; 9,920 shares on May 21, 2026; 9,900 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,640 shares on May 21, 2027; and 7,620 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028. F8 This award vests based upon the following vesting schedule: 5,050 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 5,049 shares on February 21, 2026; 5,530 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 5,529 shares on February 21, 2027; 5,797 shares on each of May 21, 2027 and August 21, 2027; 5,796 shares on each of November 21, 2027 and February 21, 2028; 10,474 shares on each of May 21, 2028, August 21, 2028, and November 21, 2028; 10,473 shares on February 21, 2029; 8,067 shares on each of May 21, 2029 and August 21, 2029; and 8,066 shares on each of November 21, 2029 and February 21, 2030. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4. References:	M Exercise / conversionCommon Stock, par value $.01 per share · Non-derivative	9,920A	0	Direct	Form 4 ↗0001557979-26-000006
2026-05-21Filed 2026-05-26	Olsavsky Brian TOfficer · Senior Vice President and CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Converts into Common Stock on a one-for-one basis. F2 This award vests based upon the following vesting schedule: 2,260 shares on May 21, 2023; 2,240 shares on each of August 21, 2023, November 21, 2023, and February 21, 2024; 3,240 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,940 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 3,920 shares on February 21, 2026; 9,920 shares on May 21, 2026; 9,900 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,640 shares on May 21, 2027; and 7,620 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028. F3 This award vests based upon the following vesting schedule: 5,050 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 5,049 shares on February 21, 2026; 5,530 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 5,529 shares on February 21, 2027; 5,797 shares on each of May 21, 2027 and August 21, 2027; 5,796 shares on each of November 21, 2027 and February 21, 2028; 10,474 shares on each of May 21, 2028, August 21, 2028, and November 21, 2028; 10,473 shares on February 21, 2029; 8,067 shares on each of May 21, 2029 and August 21, 2029; and 8,066 shares on each of November 21, 2029 and February 21, 2030. References: F1, F3	M Exercise / conversionRestricted Stock Unit Award · Derivative	5,530D	0	Direct	Form 4 ↗0001639902-26-000006

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.